The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinicopathologic features of non-small cell lung cancer (NSCLC) harboring an NTRK gene fusion.
 
Anna F. Farago
Honoraria - Foundation Medicine
Consulting or Advisory Role - Abbvie; Intervention Insights; Merrimack; PharmaMar; Takeda
Research Funding - AstraZeneca; PharmaMar
Travel, Accommodations, Expenses - Stem CentRx
 
Martin S Taylor
No Relationships to Disclose
 
Robert Charles Doebele
Honoraria - AstraZeneca; Clovis Oncology; Loxo; OxOnc; Pfizer
Consulting or Advisory Role - Array BioPharma; Lilly; Loxo; OxOnc; Pfizer; Pfizer
Research Funding - Abbott Molecular; Loxo; Mirati Therapeutics
Patents, Royalties, Other Intellectual Property - Licensing Fees for Biologic Material from Ariad (Inst); Licensing Fees for Biologic Material from Blueprint Medicines (Inst); Licensing Fees for Biologic Material from Chugai (Inst); Licensing Fees for Biologic Materials from GVKbio; Licensing Fees for Biologic Materials from Loxo Oncology (Inst); Licensing Fees from Abbott Molecular for Patent PCT/US2013/057495
Travel, Accommodations, Expenses - Ignyta
 
Alexander I. Spira
Honoraria - ARIAD; Clovis Oncology; Novartis; Roche
Consulting or Advisory Role - ARIAD; Clovis Oncology; Roche/Genentech
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Ignyta (Inst); Incyte (Inst); MedImmune (Inst); Newlink Genetics (Inst); Novartis (Inst); Roche (Inst)
Expert Testimony - Novartis
Travel, Accommodations, Expenses - ARIAD; Clovis Oncology; Roche
 
Theresa A Boyle
No Relationships to Disclose
 
Eric B. Haura
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Boehringer Ingelheim; Ignyta; Janssen; Lilly
Patents, Royalties, Other Intellectual Property - Patent pending on PLA technology related to kinase inhibitor sensitivity biomarkers
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Roxana S. Azimi
No Relationships to Disclose
 
Alice Tsang Shaw
Honoraria - Foundation medicine; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Daiichi Sankyo; EMD Serono; Genentech; Ignyta; KSQ Therapeutics; Novartis; Pfizer; Roche; Taiho Pharmaceutical
Research Funding - Novartis; Pfizer; Roche/Genentech
 
Mari Mino-Kenudson
Consulting or Advisory Role - Merrimack
 
Alexander E. Drilon
Honoraria - AstraZeneca; Blueprint Medicines; Exelixis; Genentech/Roche; Ignyta; Loxo
Consulting or Advisory Role - ARIAD
Research Funding - Foundation Medicine